FdaApplication
NDA 021567
Identifiers
- fda_app_no: NDA021567
Properties
| Property | Value |
|---|---|
| applicant_name | BRISTOL MYERS SQUIBB CO |
| application_type | NDA |
| approval_date | 2003-06-20 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REYATAZ | ATAZANAVIR SULFATE | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| REYATAZ | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE;ORAL |
| REYATAZ | ATAZANAVIR SULFATE | EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| REYATAZ | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE;ORAL |
4 products